SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Averion International Corp. (OTCBB: AVRO), a clinical research organization (CRO) specializing in oncology, cardiovascular diseases, and medical devices, today announced that its Chief Medical Officer, Dr. Gene Resnick, will be moderating a session on the “Use of Biomarkers in Drug Development” at the New York Biotechnology Association (NYBA) 17th Annual Meeting. The meeting will take place on May 19-20, 2008, at the Marriott Marquis Hotel in New York City.
